El interés en corto de ZimVie da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de ZimVie. Los datos de interés en corto se actualizan cada dos semanas.

ZimVie (NASDAQ:ZIMV) Bolsa, Informe de interés en corto

ZimVie

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

ZimVie Inc

Billionaire Elon Musk broke down the positives and negatives from the growth of robots <a href="https://www.benzinga.com/topic/artificial-intelligence">and artificial intelligence</a> in a new interview, including a fearful projection of the potential of robots taking over the world in an interview with Sen. Ted Cruz.
Growth of AI, Robots: Musk had plenty of answers for the curious Cruz about what the next five and 10 years look like for artificial intelligence, robots, <a href="https://www.benzinga.com/topic/self-driving-vehicles-0">self-driving vehicles</a> and China.
"In 10 years, AI could probably do anything better than the human can cognitively," Musk <a href="https://www.youtube.com/watch?v=BDREZmpkIz8">said</a>.
Musk predicts that "AI will be smarter than the smartest human."
The billionaire told Cruz there will be billions of humanoid robots in the next 10 years, including the Optimus bot.
Musk brushed off the notion the Optimus bot <a href="https://www.benzinga.com/general/entertainment/24/10/41314770/elon-musk-tesla-accused-of-stealing-ideas-from-i-robot-movie-for-cybercab-robovan-can-i-hav?itm_source=parsely-api">looks like the robots</a> in "I, Robot" and told Cruz that a lot of the parts of the Tesla bot will be cosmetic and can be switched out to look like something else.
"It's not meant to look like any prior robot." &nbsp;
Musk also predicts that all cars will be self-driving in the future, saying that in five years, around 50% of all miles driven will be autonomous and in 10 years, around 90% of all miles driven will be autonomous.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Risks and Concerns: Cruz highlighted there are concerns about lost jobs due to artificial intelligence. Musk has acknowledged over the years that AI could take jobs, but also make life easier for people.
"Goods and services will become close to free," Musk said.
Musk said that the billions of robots will be able to make people anything and provide any service for a "next to nothing" cost.
"It's not that people will have a lower standard of living, they'll have actually a much higher standard of living."
Cruz asked Musk about the notion of Skynet from "Terminator" becoming a reality and robots taking over the world.
Musk said this scenario is maybe 10% to 20% likely over the next five to 10 years. While this may sound negative, Musk said people should look at it as the glass being 80% to 90% full with the possibility of "extreme prosperity for all."
Musk also cautioned that America is likely to win the AI battle, but it's important to have control of the AI chips, which are currently made in Taiwan.
The billionaire said if China invades Taiwan, the world could be cut off from advanced chips.
"I think it's essential for national security."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/media/25/03/44508019/tesla-and-other-us-robotics-giants-demand-federal-strategy-to-compete-with-chinas-138-billion-push-warn-america-will-lose-the-race-without-it">Tesla And Other US Robotics Giants Demand Federal Strategy To Compete With China&#8217;s $138 Billion Push — Warn America Will Lose The Race Without It</a></li>
</ul>
Photo: Shutterstock

Tech

Elon Musk Says AI Will Be Smarter In 10 Years Than Humans, Who Will Have A 'Much Higher Standard Of Living'

News

Guidance

ACRV

Acrivon Therapeutics Says Cash Runway Extended Into 2027

Acrivon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRV#NASDAQ">ACRV</a>) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.66) by 9.09 percent. This is a 30.23 percent increase over losses of $(0.86) per share from the same period last year.

Earnings

Earnings Beats

Acrivon Therapeutics Q4 2024 GAAP EPS $(0.60) Beats $(0.66) Estimate

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) has outperformed the market over the past 5 years by 8.22% on an annualized basis producing an average annual return of 25.31%. Currently, Boston Scientific has a market capitalization of $149.09 billion. 
Buying $100 In BSX: If an investor had bought $100 of BSX stock 5 years ago, it would be worth $318.58 today based on a price of $100.80 for BSX at the time of writing.
<h3>Boston Scientific's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743111907_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today

Copper is red-hot, and so are <a href="https://www.benzinga.com/etfs">ETFs that track the industrial metal</a>. 
Prices rocketed to new records as traders responded to increasing talks of the U.S. imposing hefty tariffs on copper imports in the near future — several months before the schedule originally anticipated, according to Bloomberg citing sources familiar with the matter. 
The news rippled across global markets, sending U.S.-listed copper ETFs to record highs and fueling concerns of inflation and supply scarcity.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/03/44522702/blackrock-unveils-new-ishares-ibonds-etfs-for-fixed-income-investors">BlackRock Unveils New iShares iBonds ETFs For Fixed-Income Investors</a>
<h1 class="wp-block-heading">Copper ETFs Break Records</h1>
The copper price rally propelled ETFs tracking the metal to their highs. The $200.7 million United States Copper Index Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPER#NYSE">CPER</a>) rose more than 3% on Wednesday before backing off, taking year-to-date gains to 30% (as of writing, YTD gains is 27%). The more volatile USCF Daily Target 2X Copper Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPXR#NYSE">CPXR</a>), which started in January and seeks to replicate twice the daily return of copper futures, reached another all-time high — 45% since it started. It has since retreated slightly and currently stands at 37.64% gains since inception.
Investors have been rushing into copper ETFs during the price spike. CPER experienced $18.5 million in net inflows from March 13 to March 25, according to etf.com, indicating sustained interest in the metal. Copper miner ETFs have also reaped benefits from the spurt. The Global X Copper Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COPX#NYSE">COPX</a>), which owns leading mining stocks, has risen 7.6% year-to-date, helped by improving copper prices and investor appetite for mining stocks.
<h1 class="wp-block-heading">The Driving Force Behind The Fever</h1>
The copper tariff hype received traction following a report indicating President Donald Trump may impose a whopping 25% duties on import of all copper into the U.S. The gesture, allegedly sought to protect native production of minerals of paramount significance, forms a part of larger efforts toward diversifying American supply chains. Nevertheless, with the lengthy lead times necessitated to increase domestic mining capability, the short-term impact has been increased prices as vendors scramble to deliver copper into the U.S. prior to the imposition of tariffs, <a href="https://www.bloomberg.com/news/articles/2025-03-26/trump-may-implement-copper-import-tariffs-within-weeks?sref=TBDibEcD">reported </a>Bloomberg.
New York COMEX copper futures rose as high as 3.1% on Wednesday to a record high of $5.374 per pound before backtracking. The disparity between U.S. and world prices was stark — benchmark London Metal Exchange (LME) copper prices temporarily dipped 2.2% to $9,893 a metric ton, widening the difference between the two markets to over $1,750 a ton. This arbitrage chance initiated a worldwide sprint to reroute cargoes to the U.S., leaving major consumer China short, per Bloomberg.
Also Read: <a href="https://www.benzinga.com/25/03/44523208/new-polen-capital-etfs-target-floating-rate-loans-high-yield-bonds">Polen Capital Introduces ETFs Target Floating-Rate Loans, High-Yield Bonds</a>
<h1 class="wp-block-heading">Trade Wars, Global Supply Constraints</h1>
Copper is the newest front in the Trump administration&#8217;s relentless trade wars. The prospective tariffs follow previous tariffs on steel, aluminum and other goods, which have had a supply chain-whipping effect around the world and increased U.S. manufacturers&#8217; input costs. The threat of fresh trade barriers has again instigated fears of inflation, as increased raw material prices could percolate down through to consumers and businesses.
Supply limitations also still keep the market tight, <a href="https://www.theglobeandmail.com/investing/markets/stocks/XCG-T/pressreleases/31551635/rising-copper-prices-boost-commodity-etf-amid-tariff-fears-and-china-stimulus/">noted </a>The Globe And Mail. Declining investments in new mining operations and refining capacity have kept the sector fighting to meet demand. Even if new copper production in the U.S. increases, it will be several years before it can significantly contribute to supply, so prices can remain high for the foreseeable future.
<h1 class="wp-block-heading">What&#8217;s Next for Copper and ETFs?</h1>
With tariffs on the horizon, weeks away at worst, copper&#8217;s run could yet have some life left in it. Confirmation of duties could boost U.S. copper prices to even higher levels, increasing the arbitrage differential with the global markets. Players will be interested to see how supply chains recalibrate and whether China&#8217;s stimulus measures continue to underpin demand.
For ETF investors, the rally highlights the metal&#8217;s pivotal role in electrification, AI infrastructure and renewable energy transitions. Whether through direct copper ETFs such as CPER or mining-related funds such as COPX, the metal&#8217;s rebound offers both opportunities and threats as geopolitical and macroeconomic trends influence its path.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/03/44521217/new-rsmr-etf-balances-risk-and-reward-for-investors">New RSMR ETF Balances Risk And Reward For Investors</a></li>
</ul>
Photo: Jose Luis Stephens via Shutterstock

Specialty ETFs

Commodities

Movers

ETFs

COPX

CPER

CPXR

Red-Hot Copper: ETFs Soar On Tariff Speculation, Supply Squeeze

STMicroelectronics Reports On Resolutions To Be Proposed At 2025 AGM Of Shareholders

GameStop also granted the initial purchaser of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $200 million aggregate principal amount of notes. The sale of the notes is expected to close on April 1, 2025, subject to customary closing conditions.
GameStop expects to use the net proceeds from the offering for general corporate purposes, including the acquisition of Bitcoin in a manner consistent with GameStop's Investment Policy.

Offerings

GameStop Reports Pricing Of $1.3B Of 0.00% Convertible Senior Notes Due 2030 In Private Offering

Contracts

ASTI

Ascent Solar Secures Order For Advanced Space PV Module Design Revision

SDST

Stardust Power FY24 EPS $(0.55) Down From $(0.09) YoY

Cannabis stocks blazed higher on Thursday after former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is <a href="https://www.benzinga.com/wiim/25/03/44523271/shares-of-cannabis-stocks-are-trading-higher-after-matt-gaetz-reportedly-suggested-marijuana-reform">&#8220;on the horizon.&#8221;</a>
What Happened: Gaetz, who was U.S. President Donald Trump&#8217;s first pick for attorney general before he withdrew from consideration, suggested that &#8220;meaningful&#8221; cannabis reform is coming soon in an op-ed published by the Tampa Bay Times on Thursday.
Marijuana Moment <a href="https://www.marijuanamoment.net/trumps-first-pick-for-attorney-general-says-marijuana-rescheduling-is-on-the-horizon/">reported</a> Gaetz expressed confidence Trump will move cannabis from Schedule I to Schedule III of the Controlled Substances Act, which &#8220;won&#8217;t solve every problem,&#8221; but is a &#8220;necessary step&#8221; for cannabis reform, he said.
&#8220;There is meaningful change finally on the horizon, thanks to President Donald Trump and his leadership in supporting the rescheduling of cannabis from a Schedule I drug to a Schedule III drug,&#8221; Gaetz said.
See Also: <a href="https://www.benzinga.com/markets/cannabis/25/03/44502244/the-dea-wants-teens-to-become-anti-weed-influencers-for-25-a-pop">The DEA Wants Teens To Become Anti-Weed Influencers For $25 A Pop</a>
The report indicates Trump has not publicly discussed cannabis reform since taking office, but he did commit to rescheduling cannabis during his presidential campaign last year.
&#8220;As President, we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states rights to pass marijuana laws, like in Florida, that work so well for their citizens,&#8221; Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">said</a> in a Truth Social post in September. 
Gaetz said Thursday he believes rescheduling cannabis would help eliminate excessive tax burdens, allowing legal operators to flourish. He also expects rescheduling to lead to increased investment in the space and more access to cannabis for patients and veterans.
&#8220;This is a crucial move that will help the millions of Americans who rely on cannabis for relief, the entrepreneurs working to build a responsible industry and the veterans who deserve better treatment options. Let's get this done and continue the fight for full cannabis reform,&#8221; Gaetz said.
The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) was up more than 6% Thursday. Here&#8217;s a look at some of the biggest individual stock movers in the cannabis space:
<ul>
<li>Curaleaf Holdings Inc (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) shares closed up 12.87% at 99 cents</li>
</ul>
<ul>
<li>Tilray Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 8.97% at 71 cents</li>
</ul>
<ul>
<li>Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 4.76% at $4.62</li>
</ul>
<ul>
<li>SNDL Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 0.67% at $1.50</li>
</ul>
<ul>
<li>Canopy Growth Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed flat</li>
</ul>
<ul>
<li>Trulieve Cannabis Corp (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) shares closed up 2.11% at $3.87</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/initiation/25/03/44521557/canopy-growths-future-hinges-on-us-cannabis-regulatory-shifts-says-analyst-issuing-neutral-rating">Canopy Growth&#8217;s Future Hinges On US Cannabis Regulatory Shifts, Says Analyst, Issuing &#8216;Neutral&#8217; Rating</a></li>
</ul>
Photo: Created With Images From Shutterstock.

Cannabis

Government

Regulations

Legal

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MSOS

SNDL

TCNNF

TLRY

What Sparked The Cannabis Stock Rally On Thursday?

Yxt.Com Group Holding 2024 GAAP EPS $(0.07), Sales $45.40M

<h3>Gainers</h3>
<ul>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) shares rose 17.5% to $1.14 during Thursday's after-market session. The market value of their outstanding shares is at $9.8 million. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares rose 7.81% to $0.64. The company's market cap stands at $15.5 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) shares moved upwards by 5.99% to $0.55. The market value of their outstanding shares is at $6.3 million. </li>
<li>Phoenix Motor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) shares increased by 5.95% to $0.43. The company's market cap stands at $19.9 million. </li>
<li>China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares rose 5.44% to $2.13. The market value of their outstanding shares is at $573.6 million. </li>
<li>Mynd.ai (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) shares rose 4.99% to $0.91. The market value of their outstanding shares is at $41.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock decreased by 10.1% to $307.11 during Thursday's after-market session. The market value of their outstanding shares is at $37.4 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Oxford Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) shares declined by 7.9% to $57.6. The company's market cap stands at $904.3 million. As per the news, the Q4 earnings report came out today. </li>
<li>AYRO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYRO#NASDAQ">AYRO</a>) stock decreased by 7.3% to $0.57. The market value of their outstanding shares is at $3.8 million. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock decreased by 6.13% to $0.29. The market value of their outstanding shares is at $2.4 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) stock declined by 5.16% to $0.04. The market value of their outstanding shares is at $6.6 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) stock declined by 4.48% to $3.2. The market value of their outstanding shares is at $15.3 million. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AYRO

CLEU

GNLN

JDZG

LOBO

LULU

MYND

SPHL

WKSP

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares moved upwards by 81.6% to $8.59 during Thursday's after-market session. The company's market cap stands at $14.1 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares rose 40.69% to $0.73. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) stock moved upwards by 34.78% to $0.6. The company's market cap stands at $14.9 million. </li>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) shares rose 17.33% to $0.8. The company's market cap stands at $44.1 million. </li>
<li>Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) stock rose 8.44% to $0.43. The market value of their outstanding shares is at $26.7 million. </li>
<li>Edap TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDAP#NASDAQ">EDAP</a>) stock moved upwards by 8.1% to $2.4. The company's market cap stands at $89.0 million. As per the press release, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares decreased by 23.5% to $0.04 during Thursday's after-market session. The company's market cap stands at $1.0 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock fell 16.45% to $1.27. The company's market cap stands at $7.4 million. The company's, Q4 earnings came out today. </li>
<li>Equillium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQ#NASDAQ">EQ</a>) stock decreased by 13.86% to $0.42. The company's market cap stands at $14.8 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 11.54% to $0.07. The market value of their outstanding shares is at $9.7 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares decreased by 10.82% to $0.82. The market value of their outstanding shares is at $1.4 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock declined by 9.35% to $0.21. The market value of their outstanding shares is at $2.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EDAP

GCTK

LGMK

OCEA

PASG

PRLD

PRTG

PSTV

RNAZ

SLRX

SNSE

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock moved upwards by 37.2% to $0.9 during Thursday's after-market session. The market value of their outstanding shares is at $13.4 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares moved upwards by 16.44% to $1.7. The company's market cap stands at $406.7 million. The company's, Q4 earnings came out today. </li>
<li>Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) shares moved upwards by 14.46% to $131.9. The company's market cap stands at $1.7 billion. The company's, Q4 earnings came out today. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares increased by 8.94% to $0.95. The company's market cap stands at $7.1 million. </li>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) stock moved upwards by 7.93% to $0.8. The market value of their outstanding shares is at $121.6 million. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) stock rose 6.38% to $4.5. The market value of their outstanding shares is at $95.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) shares decreased by 9.4% to $4.68 during Thursday's after-market session. The market value of their outstanding shares is at $52.6 million. As per the press release, Q4 earnings came out today. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares fell 9.2% to $0.27. The company's market cap stands at $4.8 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares decreased by 7.63% to $0.75. The market value of their outstanding shares is at $3.1 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) shares declined by 7.06% to $0.33. The market value of their outstanding shares is at $47.6 million. As per the press release, Q4 earnings came out today. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares decreased by 6.22% to $1.51. The market value of their outstanding shares is at $111.3 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 6.14% to $0.26. The market value of their outstanding shares is at $51.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGLC

CSLR

HUHU

KULR

LNZA

NRGV

SCWO

SGLY

VTSI

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>ARB IOT Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) stock increased by 19.4% to $0.82 during Thursday's after-market session. The market value of their outstanding shares is at $21.7 million. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) shares increased by 10.12% to $6.96. The company's market cap stands at $76.0 million. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares increased by 7.89% to $1.23. The company's market cap stands at $24.1 million. </li>
<li>Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) shares increased by 7.22% to $39.35. The company's market cap stands at $4.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) stock moved upwards by 6.66% to $1.28. The company's market cap stands at $11.8 million. </li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) stock moved upwards by 5.32% to $2.77. The market value of their outstanding shares is at $21.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock decreased by 7.9% to $0.82 during Thursday's after-market session. The market value of their outstanding shares is at $16.7 million. </li>
<li>BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares declined by 6.22% to $0.8. The company's market cap stands at $2.5 million. As per the news, the Q4 earnings report came out today. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock declined by 5.37% to $0.04. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock fell 5.01% to $1.14. The market value of their outstanding shares is at $52.7 million. </li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock fell 4.97% to $0.28. The company's market cap stands at $7.3 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) shares declined by 4.68% to $2.65. The market value of their outstanding shares is at $269.4 million. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRE

ARBB

AUID

BKYI

BNZI

BRZE

BZAI

DGLY

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INTZ

MTEK

12 Information Technology Stocks Moving In Thursday's After-Market Session

The artificial intelligence boom is now colliding with America's aging energy infrastructure, but natural gas may be the unexpected wildcard that keeps the AI revolution <a href="https://www.benzinga.com/topic/artificial-intelligence">from overheating—literally.</a>
OpenAI CEO Sam Altman issued a blunt warning Thursday on social media X: "Our GPUs are melting." The comment came as OpenAI imposed temporary usage limits amid surging demand for image generation in ChatGPT. 
As tools like ChatGPT become integral to business operations, the data centers powering them are drawing electricity at unprecedented rates. Now, the race is on to secure reliable electricity supplies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">it&#39;s super fun seeing people love images in chatgpt. but our GPUs are melting. we are going to temporarily introduce some rate limits while we work on making it more efficient. hopefully won&#39;t be long! chatgpt free tier will get 3 generations per day soon.
&mdash; Sam Altman (@sama) <a href="https://twitter.com/sama/status/1905296867145154688?ref_src=twsrc%5Etfw">March 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">AI Sends US Electricity Demand Soaring: Could Natural Gas Step In To Fill The Gap?</h3>
Surging AI adoption is poised to add unprecedented pressure to the U.S. power grid, with data centers emerging as the primary energy guzzlers, according to a report released this week by Natural Gas Intelligence titled &#8216;AI Rising: How Will Natural Gas Markets Evolve to Fuel the Demand Surge?&#8217;
The International Energy Agency projects that electricity demand in the United States through 2027 will rise by an amount equivalent to California's entire current power usage. That's a surge of roughly 400 terawatt-hours (TWh) in just three years.
Wood Mackenzie estimates total U.S. electricity consumption will soar from 4,000 TWh in 2024 to 6,000 TWh by 2050. Of that, between 395 and 660 TWh could be consumed by data centers alone by 2035—more than 10% of total power usage.
The fast pace of AI deployment is leaving little room for slow build-outs of renewable energy or long-term infrastructure upgrades. That's where natural gas steps in.
"Gas will certainly get its share of the new AI-driven power demand given its reliability, which is a must for these facilities," said Patrick Rau, senior vice president of strategy and research at Natural Gas Intelligence, according to the report.
Natural gas provides firm and flexible power, a critical advantage for hyperscale data centers that operate 24/7. Rau said the key bottleneck is how quickly new gas-fired capacity can come online.
<h3 class="wp-block-heading">Utilities And Oil Giants Jump In</h3>
Power producers are already rushing to meet the call. NRG Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) is fast-tracking 1.5 gigawatts (GW) of gas-fired projects in Texas. CEO Larry Coben said the company has signed multiple letters of intent with data center developers and is advancing 10 natural gas plants totaling about 8 GW in generation capacity.
In February, NRG also partnered with GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) and construction firm Kiewit Corp. to develop up to 5.4 GW of new capacity explicitly linked to AI data centers.
Other utilities are following suit. American Electric Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) is weighing $10 billion in potential investments to meet what it calls "incremental load," largely driven by AI, manufacturing reshoring and general economic development. The company already has customer commitments for 20 GW of additional load by 2030 across its 11-state footprint.
Oil giant Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is another unexpected entrant in the AI race. In partnership with investor Engine No. 1 and GE Vernova, the energy giant plans to build co-located power plants across the Midwest, Southeast and West to support data centers with dedicated energy generation.
<h3 class="wp-block-heading">Will DeepSeek Reduce AI Data Centers Demand?</h3>
Chinese AI company DeepSeek has introduced a platform that claims to rival current models in performance—at a fraction of the power cost. That innovation, while promising, may add another twist to the AI power narrative.
"DeepSeek's improved computational efficiency may provide a pathway to quell hyperscalers' power requirement," according to a recent report by Rystad Energy experts.
"But it could also escalate the AI arms race and compel companies toward more power-intensive innovation."
For now, the message from the grid is clear: keep the pipelines flowing and the turbines spinning at full throttle.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44503568/sp-says-us-growth-to-slow-in-2025-but-recession-not-most-likely-outcome-yet">S&amp;P Says US Growth To Slow In 2025, But Recession Not &#8216;Most Likely Outcome Yet&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Large Cap

Macro Economic Events

Econ #s

Economics

Analyst Ratings

'Our GPUs Are Melting,' OpenAI's Altman Warns — Could US Natural Gas Power AI Revolution?

Sky Harbour Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#AMEX">SKYH</a>) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.10) by 370 percent. This is a 22.95 percent increase over losses of $(0.61) per share from the same period last year. The company reported quarterly sales of $4.64 million which beat the analyst consensus estimate of $4.28 million by 8.58 percent. This is a 107.42 percent increase over sales of $2.24 million the same period last year.

Earnings Misses

SKYH

Sky Harbour Group Q4 2024 GAAP EPS $(0.47) Misses $(0.10) Estimate, Sales $4.64M Beat $4.28M Estimate

PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $26.38, a high estimate of $35.00, and a low estimate of $22.00. This current average has decreased by 11.33% from the previous average price target of $29.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1743109311_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of PBF Energy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$25.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to PBF Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of PBF Energy compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of PBF Energy's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of PBF Energy's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PBF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on PBF Energy analyst ratings.</a>
<h2>About PBF Energy</h2>
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
<h3>Understanding the Numbers: PBF Energy's Finances</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining PBF Energy's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -19.56% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: PBF Energy's net margin is impressive, surpassing industry averages. With a net margin of -3.94%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): PBF Energy's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.06% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -2.24%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.42, PBF Energy adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: PBF Energy In The Eyes Of 8 Experts

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Kimberly-Clark, presenting an average target of $140.27, a high estimate of $165.00, and a low estimate of $118.00. Experiencing a 4.64% decline, the current average is now lower than the previous average price target of $147.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1743109304_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Kimberly-Clark. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$144.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$158.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$134.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$132.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$132.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$124.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Sell</td>
<td>$118.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$145.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$130.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$161.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kimberly-Clark compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Kimberly-Clark's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Kimberly-Clark's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KMB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Kimberly-Clark analyst ratings.</a>
<h2>All You Need to Know About Kimberly-Clark</h2>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Kimberly-Clark: Delving into Financials</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: Kimberly-Clark's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -0.85%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 9.07%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 42.07%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kimberly-Clark's ROA stands out, surpassing industry averages. With an impressive ROA of 2.65%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Kimberly-Clark's debt-to-equity ratio is notably higher than the industry average. With a ratio of 9.02, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Kimberly-Clark's Future

During the last three months, 4 analysts shared their evaluations of Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Alcoa and provided 12-month price targets. The average target is $45.75, accompanied by a high estimate of $51.00 and a low estimate of $40.00. This current average has decreased by 6.63% from the previous average price target of $49.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1743109295_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Alcoa's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Curt Woodworth</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$47.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Carlos De Alba</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Chris LaFemina</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Alcoa. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alcoa compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Alcoa's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Alcoa's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Alcoa analyst ratings.</a>
<h2>All You Need to Know About Alcoa</h2>
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.
<h3>Breaking Down Alcoa's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Alcoa's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 34.34%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: Alcoa's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 5.79%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Alcoa's ROE excels beyond industry benchmarks, reaching 3.88%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Alcoa's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.41%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 0.55, Alcoa faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Alcoa Stock

Press Releases

ZimVie Reports Second Quarter 2024 Financial Results

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie Reports Third Quarter 2024 Financial Results

General

ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Comments

ZimVie

Interés en corto

ZimVie (NASDAQ:ZIMV) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL